Liqrev oral suspension — United Healthcare
pulmonary arterial hypertension
Initial criteria
- Diagnosis of pulmonary arterial hypertension which is symptomatic
Reauthorization criteria
- Documentation of positive clinical response to therapy
Approval duration
12 months